Ondansetron (Compound)

Synonyms:ondansetron, 99614-02-5, Zofran, Zudan, Zophren, 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4(9H)-one, Zuplenz, 116002-70-1, 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one, GR 38032, GR 38032X, 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one, CHEBI:7773, 99614-01-4, 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one, 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one, NCGC00179341-02, DSSTox_CID_3393, SN 307, 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one, 9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one, DSSTox_RID_77011, DSSTox_GSID_23393, GR 38032 (hydrochloride);SN 307 (hydrochloride), ondansetron (Zofran), CAS-99614-02-5, Ondansetron Injection, EUR-1025, Zofran ODT (TN), DESMETHYLONDANSETRON, BRN 3622981, Ondansetron (JAN/USP/INN), Ondansetron [USP:INN:BAN], SR-01000763250, A04AA01, Ondansetron (base and/or unspecified salts), CHEMBL46, Prestwick0_001058, Prestwick1_001058, Prestwick2_001058, Prestwick3_001058, Odansetron [common misspelling of ondansetron], SCHEMBL4542, TimTec1_001750, (RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one, 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-, Oprea1_435466, Oprea1_852372, BSPBio_001016, CBDivE_008994, MLS006011928, SPBio_002938, BPBio1_001118, GTPL2290, DTXSID8023393, BDBM85330, HSDB 8304, HY-B0002B, (3S)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one, HMS2090H16, HMS3259H08, HMS3371E18, ACT02589, BCP28911, Tox21_113048, BBL010304, CAS_68647, MFCD00833882, NSC_68647, NSC791005, QC-660, s1996, STK370548, AKOS000599484, AKOS016340526, Tox21_113048_1, ACN-049703, BCP9001025, DB00904, GR-C507/75, GR38032, KS-5227, MCULE-9438746800, NC00706, NSC 757870, NSC-791005, VA11441, 1,2,3,4-Tetrahydro-9-methyl-3-(2-methyl-1H-imidazol-1-ylmethyl)carbazol-4-one, NCGC00179341-04, NCGC00179341-07, NCGC00179341-12, AC-28927, GR-38032, I544, NCI60_022780, SMR001307702, GR-38032F/GR-38032, AB0013753, GR 38032F;GR-C507/75, AB00373674

Pubchem:PUBCHEM:4595

Id:4595

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Ondansetron's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Ondansetron.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Ondansetron.

Results found

Linked to

	Label	Description
	BRD-A19736161-001-05-9 Substance (Entity type)	A Substance
	DCSTRUCT ID 01992 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01992; PubChem_CID:4595, FILE=drugcentral_drug_01992.json)
	ondansetron (a2796ea3-e607-4b78-9daa-086a2f52bc15) Collection (Entity type)	Metadatata for ondansetron
	ondansetron negatively regulates AKAP12 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ondansetron negatively regulates S100A8 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ondansetron negatively regulates CXCL9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ondansetron negatively regulates PLTP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ondansetron negatively regulates CD163 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ondansetron negatively regulates IL32 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ondansetron negatively regulates ISG20 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS